Abstract
In the original version of this article (1), 28 of 170 tumors were misclassified. The authors have updated the article text, Fig. 1, and Supplementary Table S3 to accurately reflect the decrease in positive tests from 148 to 125. The error has been corrected in the latest online HTML and PDF versions of the article. The authors regret this error. Reference 1. Meijer TG, Verkaik NS, Sieuwerts AM, van Riet J, Naipal KAT, van Deurzen CHM, et al. Functional ex vivo assay reveals homologous recombination deficiency in breast cancer beyond BRCA gene defects. Clin Cancer Res 2018;24:6277–87.
Cite
CITATION STYLE
Meijer, T. G., Verkaik, N. S., Sieuwerts, A. M., Van Riet, J., Naipal, K. A. T., Van Deurzen, C. H. M., … Van Gent, D. C. (2019). Erratum: Functional ex vivo assay reveals homologous recombination deficiency in breast cancer beyond BRCA gene defects (Clin Cancer Res. (2018)24:24(6277-6287) DOI: 10.1158/1078-0432.CCR-18-0063). Clinical Cancer Research. American Association for Cancer Research Inc. https://doi.org/10.1158/1078-0432.CCR-19-0936
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.